IMV Trademark

Trademark Overview

On Tuesday, April 24, 2018, a trademark application was filed for IMV with the United States Patent and Trademark Office. The USPTO has given the IMV trademark a serial number of 87890974. The federal status of this trademark filing is REGISTERED as of Tuesday, June 8, 2021. This trademark is owned by IMMUNOVACCINE TECHNOLOGIES, INC.. The IMV trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; laboratory research in the fields of chemistry and biochemistry; research in the field of pharmaceutical drug delivery; medical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing a website with information in the field of pharmaceutical research and development, none of the foregoing for animal applications
imv

General Information

Serial Number87890974
Word MarkIMV
Filing DateTuesday, April 24, 2018
Status700 - REGISTERED
Status DateTuesday, June 8, 2021
Registration Number6375429
Registration DateTuesday, June 8, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical research and development; laboratory research in the fields of chemistry and biochemistry; research in the field of pharmaceutical drug delivery; medical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing a website with information in the field of pharmaceutical research and development, none of the foregoing for animal applications

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, May 3, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOVAXYS TECHNOLOGY CORP.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressETOBICOKE M8W 3C4
CA
Party NameHIMV LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressFARMINGTON, CT 06032
Party NameIMMUNOVACCINE TECHNOLOGIES, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHalifax, NOVA SCOTIA B3J3R1
CA
Party NameIMMUNOVACCINE TECHNOLOGIES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHalifax, NOVA SCOTIA B3J3R1
CA
Party NameIMMUNOVACCINE TECHNOLOGIES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHalifax, NOVA SCOTIA B3J3R1
CA

Trademark Events

Event DateEvent Description
Thursday, May 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 27, 2018NEW APPLICATION ENTERED
Wednesday, May 29, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, August 14, 2018ASSIGNED TO EXAMINER
Tuesday, August 14, 2018NON-FINAL ACTION WRITTEN
Tuesday, August 14, 2018NON-FINAL ACTION E-MAILED
Tuesday, August 14, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 16, 2018SUSPENSION LETTER WRITTEN
Friday, November 16, 2018LETTER OF SUSPENSION E-MAILED
Friday, November 16, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 29, 2019SUSPENSION INQUIRY WRITTEN
Wednesday, May 29, 2019INQUIRY TO SUSPENSION E-MAILED
Wednesday, June 10, 2020SUSPENSION INQUIRY WRITTEN
Wednesday, November 27, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, December 8, 2019ASSIGNED TO LIE
Monday, December 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 9, 2019SUSPENSION LETTER WRITTEN
Monday, December 9, 2019LETTER OF SUSPENSION E-MAILED
Monday, December 9, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 10, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, June 10, 2020INQUIRY TO SUSPENSION E-MAILED
Friday, June 12, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, June 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, June 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 25, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, August 17, 2020ASSIGNED TO PETITION STAFF
Monday, August 17, 2020CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, March 11, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 10, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 10, 2021SOU EXTENSION 1 FILED
Wednesday, March 10, 2021SOU EXTENSION 1 GRANTED
Thursday, March 11, 2021NOTICE OF ALLOWANCE CANCELLED
Friday, March 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 4, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 4, 20211(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, June 8, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, October 2, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 11, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

research pharmaceutical field providing medical information development clinical trials website